Status: Recruiting
Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia
This is a dose-finding study of oral zelenirstat (PCLX-001) in patients with R/R AML. There are two parts to the study: Dose Escalation and Dose Expansion.
Participants needed: 35
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Pacylex PharmaceuticalsUpdated: Mar 10, 2025Locations: 1
Eligibility criteria
Ability to understand and the willingness to sign a written informed consent. A... [+18]
Acute promyelocytic leukemia. [+19]